Yayınlar & Eserler

Yayın Ağı
Makaleler 7
Tümü (7)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (6)
Scopus (7)
TRDizin (1)

1. Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspective

TORAMAN E., Kalın Ş. N., BAYINDIRLI K. N., GÜNAYDIN Ş., Keleş F., ALTAY A., et al.
Molecular Biology Reports , cilt.53, sa.1, 2026 (SCI-Expanded, Scopus)

2. Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells

GÜNAYDIN Ş., Kalın Ş. N., Sulukoğlu E. K., ALTAY A., BUDAK H.
Naunyn-Schmiedeberg's Archives of Pharmacology , cilt.398, sa.12, ss.17445-17458, 2025 (SCI-Expanded, Scopus)

3. Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β-Catenin Signaling Pathway in MCF-7 Cells

Kalın Ş. N., BAYINDIRLI K. N., TORAMAN E., GÜNAYDIN Ş., Keleş F., ALTAY A., et al.
Pharmacology Research and Perspectives , cilt.13, sa.4, 2025 (SCI-Expanded, Scopus)

4. Exploring natural antimicrobial properties: cell-free culture filtrates of Aspergillus niger and Rhizomucor pusillus

Berikten D., Günaydın Ş.
Biotech Studies , cilt.34, sa.2, ss.19-25, 2025 (Scopus, TRDizin)

5. Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1

Sulukoğlu E. K., Günaydın Ş., Kalın Ş. N., Altay A., Budak H.
Naunyn-Schmiedeberg's Archives of Pharmacology , cilt.397, sa.8, ss.5745-5755, 2024 (SCI-Expanded, Scopus)

6. Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells

Günaydın Ş., Sulukoğlu E. K., Kalın Ş. N., Altay A., Budak H.
Journal of Applied Toxicology , cilt.43, sa.11, ss.1676-1685, 2023 (SCI-Expanded, Scopus)

7. Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress

Avci S., Gunaydin Ş., Kurtcan N. S., Sulukoglu E. K., Polat O. E., Gecili I., et al.
JOURNAL OF MOLECULAR NEUROSCIENCE , cilt.72, sa.11, ss.2292-2302, 2022 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 10

1. Anticancer Potential of Lobaric Acid in Breast Cancer: Role of Oxidative Stress

Kalın Ş. N., Bayındırlı K. N., Toraman E., Günaydın Ş., Keleş F., Altay A., et al.
7th Eurasia Biochemical Approaches & Technologies (EBAT), Antalya, Türkiye, 6 - 09 Kasım 2025, ss.104, (Özet Bildiri)

2. ANTI-CANCER POTENTIAL OF SHORT-CHAIN FATTY ACIDS (SCFA) PRODUCED IN MICROBIALCELL FACTORIES

Öztürk E. Z., Günaydın Ş., Berikten D.
INTERNATIONAL BALIKESIR ACADEMIC RESEARCH CONGRESS ON HEALTH SCIENCES, Balıkesir, Türkiye, 10 - 12 Ekim 2025, (Tam Metin Bildiri)

3. CHLOROGENIC ACID: MICROBIAL RESOURCES AND INHIBITION POTENTIAL IN CANCERMETASTASIS

Günaydın Ş., Öztürk E. Z., Berikten D.
INTERNATIONAL BALIKESIR ACADEMIC RESEARCH CONGRESS ON HEALTH SCIENCES, Balıkesir, Türkiye, 10 - 12 Ekim 2025, (Tam Metin Bildiri)

4. Exploring the Role of Mitochondrial Membrane Potential in Lung Cancer: Natural Compounds as Potential Therapeutic Agents

GÜNAYDIN Ş., MERİÇ N.
9th International Acharaka Congress on Medicine, Nursing, Midwifery, and Health Sciences, Ürgenç, Özbekistan, 14 - 16 Aralık 2024, ss.1230-1236, (Tam Metin Bildiri)

5. As natural antimicrobial agents: Cell-free culture filtrate of Aspergillus niger and Rhizomucor pusillus

Berikten D., Günaydın Ş.
6th Eurasia Biochemical Approaches & Technologies (6. EBAT) , Tokat, Türkiye, 24 - 27 Ekim 2024, ss.78, (Özet Bildiri)

6. Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4-Aminoquinazoline Derivatives on Human Lung (A-549) Cancer Cell Line

Polat E., Günaydın Ş., Budak H., Çakıcı M.
12th International Drug Chemistry Congress, Antalya, Türkiye, 7 - 10 Mart 2024, ss.136, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Evaluation of Thioredoxin Reductase 1-Targeted Anticancer Effect of Evernic Acid on Human Lung Cancer A549 Cell Line

GÜNAYDIN Ş., KALIN Ş. N., KARACA E., ALTAY A., BUDAK H.
4th Eurasia Biochemical Approaches & Technologies Congress (4. EBAT), Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)

8. Anti-cancer Effect of Diffractaic Acid on Hepatocellular Carcinoma through Inducing of Apoptosis and Suppression of Metastasis

KARACA E., GÜNAYDIN Ş., KALIN Ş. N., ALTAY A., BUDAK H.
3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

9. Investigation of Thioredoxin Reductase-Targeted Anticancer Effect of Diffractaic Acid on Human Lung Cancer

GÜNAYDIN Ş., KARACA E., KALIN Ş. N., ALTAY A., BUDAK H.
3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

10. Investigation of Anti-Cancer Effects of Enantiomerically Pure (S)-4- Aminoquinazoline Derivatives on Human Liver (HepG2) Cancer Cell Line

POLAT E., KARACA E., GÜNAYDIN Ş., BUDAK H., ÇAKICI M.
3rd Eurasia Biochemical Approaches & Technologies Congress (3. EBAT), Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)
Kitaplar 1

1. Antimicrobial Peptides: An Anticancer Effect on Hepatocellular Carcinoma by Modulating Their Mitochondrial Membrane Potential

GÜNAYDIN Ş., BERİKTEN D.
Contemporary Approaches in Health Sciences, HATİPOĞLU FATİH, Editör, All Sciences Academy, ss.192-203, 2024
Metrikler

Yayın

18

Yayın (WoS)

6

Yayın (Scopus)

7

Atıf (Scopus)

59

H-İndeks (Scopus)

4

Atıf (Scholar)

52

H-İndeks (Scholar)

3

Toplam Atıf Sayısı

59

Proje

3
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER